in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – February 7
8:32 AM MST | February 7, 2012 | Deepti Ramesh
LONZA REPLACES CEO AFTER DECLINE IN EARNINGS Lonza has suddenly fired CEO Stefan Borgas following a series of weak financial results. The company announced plans last month to appoint a new CEO and, during a transitional period Rolf Soiron, Lonza chairman, will coordinate its management committee. The weak results follow Lonza’s acquisition of biocides maker Arch Chemicals (Norwalk, CT) for $1.4 billion last October. “With the acquisition of Arch in 2011, Lonza achieved another step in its transformation toward a global life science company,”...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee